Gene sequencing technology company 10x Genomics (TXG 2.52%) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and according to data compiled by S&P Global Market Intelligence its price was down by more than 9% week to date as of early Friday morning.Morgan Stanley makes a cutThat occurred on Monday, when Tejas Savant from white-shoe investment bank Morgan Stanley reduced his 10x Genomics price target to $18 per share, far down from ...